J Med Chem. 2009 Jan 22;52(2):514-23.

Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer.

Penning TD, Zhu GD, Gandhi VB, Gong J, Liu X, Shi Y, Klinghofer V, Johnson EF, Donawho CK, Frost DJ, Bontcheva-Diaz V, Bouska JJ, Osterling DJ, Olson AM, Marsh KC, Luo Y, Giranda VL.

Source

Cancer Research, Pharmacokinetics, GPRD, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064, USA. thomas.penning@abbott.com

Abstract

We have developed a series of cyclic amine-containing benzimidazole carboxamide PARP inhibitors with a methyl-substituted quaternary center at the point of attachment to the benzimidazole ring system. These compounds exhibit excellent PARP enzyme potency as well as single-digit nanomolar cellular potency. These efforts led to the identification of 3a (2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide, ABT-888), currently in human phase I clinical trials. Compound 3a displayed excellent potency against both the PARP-1 and PARP-2 enzymes with a K(i) of 5 nM and in a C41 whole cell assay with an EC(50) of 2 nM. In addition, 3a is aqueous soluble, orally bioavailable across multiple species, and demonstrated good in vivo efficacy in a B16F10 subcutaneous murine melanoma model in combination with temozolomide (TMZ) and in an MX-1 breast cancer xenograft model in combination with either carboplatin or cyclophosphamide.

PMID:: 19143569; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Chemical Information

BindingDB

Molecular Biology Databases

Supplemental Content

Related citations

Optimization of phenyl-substituted benzimidazole carboxamide poly(ADP-ribose) polymerase inhibitors: identification of (S)-2-(2-fluoro-4-(pyrrolidin-2-yl)phenyl)-1H-benzimidazole-4-carboxamide (A-966492), a highly potent and efficacious inhibitor. [J Med Chem. 2010]
Optimization of phenyl-substituted benzimidazole carboxamide poly(ADP-ribose) polymerase inhibitors: identification of (S)-2-(2-fluoro-4-(pyrrolidin-2-yl)phenyl)-1H-benzimidazole-4-carboxamide (A-966492), a highly potent and efficacious inhibitor.
Penning TD, Zhu GD, Gong J, Thomas S, Gandhi VB, Liu X, Shi Y, Klinghofer V, Johnson EF, Park CH, et al. J Med Chem. 2010 Apr 22; 53(8):3142-53.
Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer. [Bioorg Med Chem. 2008]
Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer.
Penning TD, Zhu GD, Gandhi VB, Gong J, Thomas S, Lubisch W, Grandel R, Wernet W, Park CH, Fry EH, et al. Bioorg Med Chem. 2008 Jul 15; 16(14):6965-75. Epub 2008 May 27.
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models. [Clin Cancer Res. 2007]
ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models.
Donawho CK, Luo Y, Luo Y, Penning TD, Bauch JL, Bouska JJ, Bontcheva-Diaz VD, Cox BF, DeWeese TL, Dillehay LE, et al. Clin Cancer Res. 2007 May 1; 13(9):2728-37.
Review PARP inhibitors for cancer therapy. [Expert Rev Mol Med. 2005]
Review PARP inhibitors for cancer therapy.
Curtin NJ. Expert Rev Mol Med. 2005 Mar 15; 7(4):1-20. Epub 2005 Mar 15.
Review Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology. [Clin Cancer Res. 2007]
Review Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology.
Ratnam K, Low JA. Clin Cancer Res. 2007 Mar 1; 13(5):1383-8.

See reviews... See all...

Cited by 7 PubMed Central articles

The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy. [Ther Adv Med Oncol. 2011]
The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy.
Javle M, Curtin NJ. Ther Adv Med Oncol. 2011 Nov; 3(6):257-67.
PARP-1 and PARP-2: New players in tumour development. [Am J Cancer Res. 2011]
PARP-1 and PARP-2: New players in tumour development.
Yelamos J, Farres J, Llacuna L, Ampurdanes C, Martin-Caballero J. Am J Cancer Res. 2011; 1(3):328-346. Epub 2011 Jan 8.
The ups and downs of DNA repair biomarkers for PARP inhibitor therapies. [Am J Cancer Res. 2011]
The ups and downs of DNA repair biomarkers for PARP inhibitor therapies.
Wang X, Weaver DT. Am J Cancer Res. 2011; 1(3):301-327. Epub 2010 Jan 3.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioAssay
PubChem BioAssay experiments on the biological activities of small molecules that cite the current articles. The depositors of BioAssay data provide these references.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyr...
Discovery of the Poly(ADP-ribose) polymerase (PARP) inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the treatment of cancer.
J Med Chem. 2009 Jan 22 ;52(2):514-23.

PubMed
Mechanism and regulation of yeast RNA polymerase II transcription.
Mechanism and regulation of yeast RNA polymerase II transcription.
Cold Spring Harb Symp Quant Biol. 1998 ;63:229-32.

PubMed
The ischiopubic synchondrosis: changing appearance on PET/CT as a mimic of disea...
The ischiopubic synchondrosis: changing appearance on PET/CT as a mimic of disease.
Clin Nucl Med. 2006 Jul ;31(7):414-7.

PubMed
Reflex bladder activation via pudendal nerve and intraurethral stimulation depen...
Reflex bladder activation via pudendal nerve and intraurethral stimulation depends on stimulation pattern and location.
Conf Proc IEEE Eng Med Biol Soc. 2008 ;2008:2760-3.

PubMed
Febrile seizures and mesial temporal sclerosis: No association in a long-term fo...
Febrile seizures and mesial temporal sclerosis: No association in a long-term follow-up study.
Neurology. 2003 Jan 28 ;60(2):215-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: